Literature DB >> 3258872

Comparison of two dimensional immunoelectrophoresis and multimer analysis in the study of von Willebrand factor.

M A Howard1, A Oates, B G Firkin.   

Abstract

To assess the validity of the multimeric analysis of von Willebrand factor (vWf), this technique was compared with two dimensional immunoelectrophoresis using samples of purified vWf obtained by gel filtration and plasma samples from a patient with severe von Willebrands disease who was receiving prophylaxis with cryoprecipitate. It is concluded that except for specialised clinical and research purposes, two dimensional immunoelectrophoresis provides a clear picture of the multimeric composition of the vWf molecule, and that this is sufficient for routine research and clinical use, without having to confirm the data by multimeric analysis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3258872      PMCID: PMC1141438          DOI: 10.1136/jcp.41.3.346

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  24 in total

1.  Determination of the von Willebrand's disease antigen (factor VIII-related antigen) in plasma by quantitative immunoelectrophoresis.

Authors:  T S Zimmerman; L W Hoyer; L Dickson; T S Edgington
Journal:  J Lab Clin Med       Date:  1975-07

2.  Letter: A method for assaying von Willebrand factor (ristocetin cofactor).

Authors:  D E Macfarlane; J Stibbe; E P Kirby; M B Zucker; R A Grant; J McPherson
Journal:  Thromb Diath Haemorrh       Date:  1975-09-30

3.  MEASUREMENT OF PLATELET ADHESIVENESS. A SIMPLE IN VITRO TECHNIQUE DEMONSTRATING AN ABNORMALITY IN VON WILLEBRAND'S DISEASE.

Authors:  E W SALZMAN
Journal:  J Lab Clin Med       Date:  1963-11

4.  A two-site, monoclonal antibody-based immunoassay for von Willebrand factor--demonstration that vWF function resides in a conformational epitope.

Authors:  S Chand; A McCraw; R Hutton; E G Tuddenham; A H Goodall
Journal:  Thromb Haemost       Date:  1986-06-30       Impact factor: 5.249

5.  Proteolytic cleavage of human von Willebrand factor induced by enzyme(s) released from polymorphonuclear cells.

Authors:  E A Thompson; M A Howard
Journal:  Blood       Date:  1986-05       Impact factor: 22.113

6.  A new variant of dominant type II von Willebrand's disease with aberrant multimeric pattern of factor VIII-related antigen (type IID).

Authors:  S Kinoshita; J Harrison; J Lazerson; C F Abildgaard
Journal:  Blood       Date:  1984-06       Impact factor: 22.113

7.  Human von Willebrand factor: a multivalent protein composed of identical subunits.

Authors:  M W Chopek; J P Girma; K Fujikawa; E W Davie; K Titani
Journal:  Biochemistry       Date:  1986-06-03       Impact factor: 3.162

8.  The agglutination of human platelets by botrocetin: evidence that botrocetin and ristocetin act at different sites on the factor VIII molecule and platelet membrane.

Authors:  M A Howard; J Perkin; H H Salem; B G Firkin
Journal:  Br J Haematol       Date:  1984-05       Impact factor: 6.998

9.  Active release of human platelet factor VIII-related antigen by adenosine diphosphate, collagen, and thrombin.

Authors:  J Koutts; P N Walsh; E F Plow; J W Fenton; B N Bouma; T S Zimmerman
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

10.  Amino acid sequence of human von Willebrand factor.

Authors:  K Titani; S Kumar; K Takio; L H Ericsson; R D Wade; K Ashida; K A Walsh; M W Chopek; J E Sadler; K Fujikawa
Journal:  Biochemistry       Date:  1986-06-03       Impact factor: 3.162

View more
  1 in total

1.  Inheritance and prevalence of von Willebrand's disease severe form in a Brazilian population.

Authors:  R R Fischer; C Lerner; E Bandinelli; A S Fonseca; I Roisenberg
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.